Heparin management and hemostatic risk evaluation in patients undergoing pulmonary thrombo-endarterectomy

Completed

• Conditions: Chronic pulmonary embolism; Pulmonary hypertension; 10037454; 10003184; 10014523

• Registration Number: NL-OMON42520
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 25

Inclusion Criteria

• Adult subjects (age 18-85 years)
• Informed consent

Exclusion Criteria

• Re-operation
• Hereditary hemoglobinopathies

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Perioperative changes in the activated clotting time (ACT) and heparin<br /><br>concentration</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Perioperative changes in thromboelastometric parameters and platelet<br /><br>aggregation</p><br>